SJS Investment Consulting’s Takeda Pharmaceutical TAK Stock Holding History

SJS Investment Consulting’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.6K	Buy	2,285 +817	+56%	+$13.5K	﹤0.01%	577
2026 Q1	$27.2K	Buy	1,468 +507	+53%	+$8.9K	﹤0.01%	584
2025 Q4	$15K	Buy	+961	New	+$13.7K	﹤0.01%	695
2022 Q4	–	Sell	-604	Closed	-$8K	–	1704
2022 Q3	$8K	Buy	+604	New	+$8.4K	﹤0.01%	305
2022 Q1	$9K	Hold	604	–	–	﹤0.01%	402
2021 Q4	$8K	Buy	+604	New	+$8.47K	﹤0.01%	392

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

SJS Investment Consulting's TAK Position: Q2 2026 in Review

SJS Investment Consulting increased its Takeda Pharmaceutical (TAK) stake by 56% in Q2 2026, buying an estimated $13.5K and bringing the position to 2,285 shares worth $36.6K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

SJS Investment Consulting first reported a position in TAK in Q4 2021 and has held it in 6 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

SJS Investment Consulting held 2,285 shares of Takeda Pharmaceutical worth $36.6K as of Q2 2026.
SJS Investment Consulting bought 817 Takeda Pharmaceutical shares in Q2 2026, an estimated $13.5K.
Takeda Pharmaceutical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #577 holding.
SJS Investment Consulting first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 6 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.